Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 834

1.

Neural evidence for the intrinsic value of action as motivation for behavior.

Miura N, Tanabe HC, Sasaki A, Harada T, Sadato N.

Neuroscience. 2017 Apr 8. pii: S0306-4522(17)30239-7. doi: 10.1016/j.neuroscience.2017.03.064. [Epub ahead of print]

PMID:
28396007
2.

Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer.

Kakuya T, Mori T, Yoshimoto S, Watabe Y, Miura N, Shoji H, Onidani K, Shibahara T, Honda K.

Int J Oral Maxillofac Surg. 2017 Apr 3. pii: S0901-5027(17)31345-0. doi: 10.1016/j.ijom.2017.03.001. [Epub ahead of print]

PMID:
28385383
3.

Chronotoxicity of bromobenzene-induced hepatic injury in mice.

Yoshioka H, Nonogaki T, Fukuishi N, Shinohara Y, Hwang GW, Ohtani K, Miura N.

J Toxicol Sci. 2017;42(2):251-258. doi: 10.2131/jts.42.251.

4.

Akr1 attenuates methylmercury toxicity through the palmitoylation of Meh1 as a subunit of the yeast EGO complex.

Zhang ZT, Ogiwara Y, Ito Y, Hikida A, Miura N, Kuge S, Naganuma A, Hwang GW.

Biochim Biophys Acta. 2017 Mar 15. pii: S0304-4165(17)30092-2. doi: 10.1016/j.bbagen.2017.03.009. [Epub ahead of print]

PMID:
28315413
5.

Acid-base disturbances in nephrotic syndrome: analysis using the CO2/HCO3 method (traditional Boston model) and the physicochemical method (Stewart model).

Kasagi T, Imai H, Miura N, Suzuki K, Yoshino M, Nobata H, Nagai T, Banno S.

Clin Exp Nephrol. 2017 Mar 13. doi: 10.1007/s10157-017-1387-8. [Epub ahead of print]

PMID:
28289910
6.

Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.

Miura N, Akita H, Tateshita N, Nakamura T, Harashima H.

Mol Ther. 2017 Apr 5;25(4):1003-1013. doi: 10.1016/j.ymthe.2017.01.020. Epub 2017 Feb 22.

7.

Stage IV pleomorphic carcinoma of the lung without recurrence for 6 years: a case report.

Miura N, Mori R, Takenaka T, Yamazaki K, Momosaki S, Takeo S.

Surg Case Rep. 2017 Dec;3(1):36. doi: 10.1186/s40792-017-0310-6. Epub 2017 Feb 21.

8.

Non-receptor type, proline-rich protein tyrosine kinase 2 (Pyk2) is a possible therapeutic target for Kawasaki disease.

Suzuki C, Nakamura A, Miura N, Fukai K, Ohno N, Yahata T, Okamoto-Hamaoka A, Fujii M, Yoshioka A, Kuchitsu Y, Ikeda K, Hamaoka K.

Clin Immunol. 2017 Feb 3;179:17-24. doi: 10.1016/j.clim.2017.01.013. [Epub ahead of print]

PMID:
28167306
9.

Light Chain Deposition Disease Diagnosed with Laser Micro-dissection, Liquid Chromatography, and Tandem Mass Spectrometry of Nodular Glomerular Lesions.

Kasagi T, Nobata H, Suzuki K, Miura N, Banno S, Takami A, Yamashita T, Ando Y, Imai H.

Intern Med. 2017;56(1):61-66. doi: 10.2169/internalmedicine.56.7275. Epub 2017 Jan 1.

10.

A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis.

Miyabe C, Miyabe Y, Komiya T, Shioya H, Miura NN, Takahashi K, Ohno N, Tsuboi R, Luster AD, Kawai S, Miyasaka N, Nanki T.

Inflamm Res. 2017 Apr;66(4):335-340. doi: 10.1007/s00011-016-1018-y. Epub 2016 Dec 10.

PMID:
27942751
11.

Two Cases of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody (PR3-ANCA)-related Nephritis in Infectious Endocarditis.

Hirai K, Miura N, Yoshino M, Miyamoto K, Nobata H, Nagai T, Suzuki K, Banno S, Imai H.

Intern Med. 2016;55(23):3485-3489. Epub 2016 Dec 1.

12.

Left Lateral Prefrontal Activity Reflects a Change of Behavioral Tactics to Cope with a Given Rule: An fNIRS Study.

Miura N, Shirasawa N, Kanoh S.

Front Hum Neurosci. 2016 Nov 1;10:558. eCollection 2016.

13.

Genetic Phagocyte NADPH Oxidase Deficiency Enhances Nonviable Candida albicans-Induced Inflammation in Mouse Lungs.

Endo D, Fujimoto K, Hirose R, Yamanaka H, Homme M, Ishibashi KI, Miura N, Ohno N, Aratani Y.

Inflammation. 2017 Feb;40(1):123-135. doi: 10.1007/s10753-016-0461-9.

PMID:
27785664
14.

Foxc2CreERT2 knock-in mice mark stage-specific Foxc2-expressing cells during mouse organogenesis.

Amin MB, Miura N, Uddin MK, Islam MJ, Yoshida N, Iseki S, Kume T, Trainor PA, Saitsu H, Aoto K.

Congenit Anom (Kyoto). 2017 Jan;57(1):24-31. doi: 10.1111/cga.12198.

PMID:
27783871
15.

Role of the preoperative usefulness of the pathological diagnosis of pancreatic diseases.

Matsumoto K, Takeda Y, Onoyama T, Kawata S, Kurumi H, Ueki M, Miura N, Isomoto H.

World J Gastrointest Oncol. 2016 Sep 15;8(9):656-62. doi: 10.4251/wjgo.v8.i9.656. Review.

16.

FOXC2 augments tumor propagation and metastasis in osteosarcoma.

Gozo MC, Jia D, Aspuria PJ, Cheon DJ, Miura N, Walts AE, Karlan BY, Orsulic S.

Oncotarget. 2016 Oct 18;7(42):68792-68802. doi: 10.18632/oncotarget.11990.

17.

Plasminogen activator inhibitor type 1 in platelets induces thrombogenicity by increasing thrombolysis resistance under shear stress in an in-vitro flow chamber model.

Hosokawa K, Ohnishi-Wada T, Sameshima-Kaneko H, Nagasato T, Miura N, Kikuchi K, Koide T, Maruyama I, Urano T.

Thromb Res. 2016 Oct;146:69-75. doi: 10.1016/j.thromres.2016.09.002. Epub 2016 Sep 4.

PMID:
27611498
18.

High-dose Cepharanthin for pediatric chronic immune thrombocytopenia in Japan.

Yamazaki T, Shibuya A, Ishii S, Miura N, Ohtake A, Sasaki N, Araki R, Ota Y, Fujiwara M, Miyajima Y, Uetake K, Hamahata K, Kato K, Kawakami K, Toyoda H, Moriguchi N, Okada M, Nishi M, Ogata Y, Takimoto T, Ohga S, Ohta S, Amemiya S.

Pediatr Int. 2017 Mar;59(3):303-308. doi: 10.1111/ped.13151. Epub 2016 Nov 13.

PMID:
27596055
19.

Suppressive Effect of Kampo Formula "Juzen-taiho-to" on Carbon Tetrachloride-Induced Hepatotoxicity in Mice.

Yoshioka H, Fukaya S, Miura N, Onosaka S, Nonogaki T, Nagatsu A.

Biol Pharm Bull. 2016;39(9):1564-7. doi: 10.1248/bpb.b16-00421.

20.

Pharmacokinetic Interaction Study of Ranitidine and Daijokito in Healthy Volunteers.

Endo Y, Ishihara Y, Tsuno S, Matsuda A, Qian W, Miura N, Hasegawa J.

Yonago Acta Med. 2016 Jun 29;59(2):111-7. eCollection 2016 Jun.

Supplemental Content

Support Center